Improvement of Refractory Chronic Actinic Dermatitis During Tofacitinib Treatment

Am J Ther. 2023 Nov-Dec;30(6):e547-e548. doi: 10.1097/MJT.0000000000001616. Epub 2023 Mar 1.

Authors

Ying-Jun Wang^{1

2}, Hai-Zhen Hui^{1

2}, Jia-Rong Cheng^{1

2}, Han Mao^{1

2}, Qing-Chun Diao¹, Bing-Jun Shi¹

Affiliations

¹ Department of Dermatology, Chongqing Hospital of Traditional Chinese Medicine (Chongqing Key Laboratory of Integrative Dermatology Research; Chongqing Clinical Research Center for Dermatology), Chongqing, People's Republic of China; and.
² Guizhou University of Traditional Chinese Medicine, Guiyang, People's Republic of China.

PMID: 36856587
DOI: 10.1097/MJT.0000000000001616

No abstract available

Publication types

Letter

MeSH terms

Humans
Photosensitivity Disorders* / chemically induced
Photosensitivity Disorders* / drug therapy
Piperidines / therapeutic use
Pyrimidines / therapeutic use

Substances

tofacitinib
Piperidines
Pyrimidines